Dr. Christiane Querfeld, MD
Claim this profileCity of Hope
Studies Cutaneous T-Cell Lymphoma
Studies Mycosis Fungoides/Sezary Syndrome
6 reported clinical trials
10 drugs studied
Area of expertise
1Cutaneous T-Cell Lymphoma
Stage I
Stage II
Stage III
2Mycosis Fungoides/Sezary Syndrome
Stage I
Stage II
Stage III
Affiliated Hospitals
Clinical Trials Christiane Querfeld, MD is currently running
Photopheresis + Mogamulizumab
for Cutaneous T-Cell Lymphoma
This phase II trial studies the effect of extracorporeal photopheresis (ECP) and mogamulizumab in treating patients with erythrodermic cutaneous T cell lymphoma (CTCL), a type of skin lymphoma. CTCL is a rare type of cancer that begins in the white blood cells called T cells. Erythrodermic is a widespread red rash that may cover most of the body. ECP is a medical treatment that removes blood with a machine, isolates white blood cells and exposes them to ultra violet light, then returns the cells to the body. Mogamulizumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Giving mogamulizumab with ECP may work together to kill the tumor cells directly (with mogamulizumab) and boost immune response to cancer (with ECP).
Recruiting1 award Phase 2
Fenretinide
for T-Cell Lymphoma
This study evaluates a fenretinide phospholipid suspension for the treatment of T-cell non-Hodgkin's lymphoma (NHL).
Recruiting1 award Phase 1
More about Christiane Querfeld, MD
Clinical Trial Related3 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Christiane Querfeld, MD has experience with
- Fenretinide
- Extracorporeal Photopheresis
- Mogamulizumab
- Durvalumab
- Lenalidomide
- External-beam Radiotherapy (XRT)
Breakdown of trials Christiane Querfeld, MD has run
Cutaneous T-Cell Lymphoma
Mycosis Fungoides/Sezary Syndrome
Sezary Syndrome
Mycosis Fungoides
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christiane Querfeld, MD specialize in?
Christiane Querfeld, MD focuses on Cutaneous T-Cell Lymphoma and Mycosis Fungoides/Sezary Syndrome. In particular, much of their work with Cutaneous T-Cell Lymphoma has involved Stage I patients, or patients who are Stage II.
Is Christiane Querfeld, MD currently recruiting for clinical trials?
Yes, Christiane Querfeld, MD is currently recruiting for 3 clinical trials in Duarte California. If you're interested in participating, you should apply.
Are there any treatments that Christiane Querfeld, MD has studied deeply?
Yes, Christiane Querfeld, MD has studied treatments such as Fenretinide, Extracorporeal Photopheresis, Mogamulizumab.
What is the best way to schedule an appointment with Christiane Querfeld, MD?
Apply for one of the trials that Christiane Querfeld, MD is conducting.
What is the office address of Christiane Querfeld, MD?
The office of Christiane Querfeld, MD is located at: City of Hope, Duarte, California 91010 United States. This is the address for their practice at the City of Hope.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.